41 – 50 of 362
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Harnessing androgen receptor pathway activation for targeted alpha particle radioimmunotherapy of breast cancer
(
- Contribution to journal › Article
-
Mark
Perspective on prostate cancer screening
(
- Contribution to journal › Scientific review
-
Mark
Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men
(
- Contribution to journal › Article
-
Mark
Kallikrein markers performance in pretreatment blood to predict early prostate cancer recurrence and metastasis after radical prostatectomy among very high-risk men
2019) In Prostate(
- Contribution to journal › Article
-
Mark
A urinary extracellular vesicle microRNA biomarker discovery pipeline; from automated extracellular vesicle enrichment by acoustic trapping to microRNA sequencing
(
- Contribution to journal › Article
-
Mark
Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy
(
- Contribution to journal › Article
-
Mark
The role of plasma microseminoprotein-beta in prostate cancer : An observational nested case-control and Mendelian randomization study in the European prospective investigation into cancer and nutrition
(
- Contribution to journal › Article
-
Mark
Interim Results from the IMPACT Study : Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
(
- Contribution to journal › Article
-
Mark
Reply to Kathryn L. Penney, Massimo Loda, and Meir J. Stampfer's Letter to the Editor re : Melissa Assel, Anders Dahlin, David Ulmert, et al. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening. Eur Urol 2018;73:961–7
(
- Contribution to journal › Letter
-
Mark
Clinical chemistry’s special issue on men’s health
(
- Contribution to journal › Debate/Note/Editorial